Illumina Inc (NAS:ILMN)
$ 151.5 0.41 (0.27%) Market Cap: 24.03 Bil Enterprise Value: 25.76 Bil PE Ratio: 0 PB Ratio: 11.26 GF Score: 80/100

Illumina Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 17, 2023 / 04:00PM GMT
Release Date Price: $164.96 (+0.10%)
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

Hi I'm John Sourbeer, one of the Life Sciences analyst here at UBS. Final day of the 2023 UBS Life Sciences Conference here (inaudible) the Life Science portion here with a fireside chat with Illumina. Joining us today is Sally Schwartz, VP of Investor Relations. Sally, thanks for joining us.

Sallilyn Schwartz
Illumina, Inc. - VP of IR

Thank you for having me.

John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

So you guys recently reported 2Q earnings last week, but maybe just start off with a recap in the lower guidance. There's certainly been larger macro issues throughout the life sciences industry, but maybe some of the puts and takes on China slower-than-expected NovaSeq X ramp and some of the general budget pressures across customers.

Sallilyn Schwartz
Illumina, Inc. - VP of IR

Sure. And maybe just as a quick recap. We previously had

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot